type here...

CATEGORIES

Press Release

LATEST

Editors Choice

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Medika Life -
Editors Choice

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

Medika Life -
Editors Choice

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Medika Life -
Editors Choice

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

Medika Life -
Editors Choice

GE HealthCare and Biofourmis Collaborate to Extend Patient Monitoring Outside the Hospital with Virtual Care-at-Home Solutions

Medika Life -
Injury

Sheba Medical Center Selects Two Digital Startups for Integration into Newly Expanded Rehabilitation Ward

Medika Life -
Health Insurance

Benchmark KFF Survey: Annual Family Premiums for Employer Coverage Rise 7% to Nearly $24,000 in 2023

Medika Life -
Editors Choice

KFF Survey Shows Complexity, Red Tape, Denials, Confusion Rivals Affordability as a Problem for Insured Consumers, With Some Saying It Caused Them to Go...

Medika Life -
Editors Choice

Clinics IV Life Launches a New Clinic Model to Change the Face of Charitable Maternal Care, Delivery to Impoverished Communities

Robert Turner, Founding Editor -
Press Release

The Journal – Artificial Intelligence in the Life Sciences – Highlights the Contributions of Women in Artificial Intelligence in the Life Sciences

Medika Life -
123...12Page 1 of 12

TRENDING

EDITORS CHOICE

ACOG Statement on the Johnson & Johnson COVID-19 Vaccine

Medika Life -
ACOG issues a statement to its members on the temporary withdrawal of the Johnson & Johnson vaccine following reports of rare blood clotting condition.

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

Medika Life -
New Non-Profit Organization Focuses on Early-Stage Sponsored Research and Venture Philanthropy to Advance Human Health and Well-being

Opdivo® Approved for the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Medika Life -
FDA Approved Opdivo demonstrated superior overall survival benefit compared to docetaxel or paclitaxel in ESCC Patients

Research into gut microbiome-autism link reveals new perspective

Medika Life -
Latest research on the gut biome and Autism fails to demonstrate a an association between the microbiome and a diagnosis of ASD

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories